Drugs / Viscum album
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT06920810 | Mar 2025 → Dec 2027 expected | triple-negative breast carcinoma | Ilsan Cha hospital | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01527760 | Feb → Aug 2011 | hypertensive disorder | Fr Muller Homoeopathic Medical College | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | viscum album | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06920810 ↗ |
| Known as | Viscum album mother tincture | “Clinical evaluation of Viscum album mother tincture as an antihypertensive: a pilot study.” PMID 24647376 ↗ Nov 2013 |
| Route | Subcutaneous | “Administered subcutaneously three times per week” NCT06920810 ↗ |